Join

Compare · AKYA vs BRKR

AKYA vs BRKR

Side-by-side comparison of Akoya BioSciences Inc. (AKYA) and Bruker Corporation (BRKR): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AKYA and BRKR operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • BRKR is the larger of the two at $9.72B, about 25.0x AKYA ($388.8M).
  • Over the past year, AKYA is up 11.1% and BRKR is up 65.8% - BRKR leads by 54.7 points.
  • BRKR has hit the wire 11 times in the past 4 weeks while AKYA has been quiet.
  • BRKR has more recent analyst coverage (22 ratings vs 13 for AKYA).
PerformanceAKYA+11.11%BRKR+72.25%
2025-06-04+0.00%2025-07-07
MetricAKYABRKR
Company
Akoya BioSciences Inc.
Bruker Corporation
Price
$1.30-5.80%
$62.69+9.29%
Market cap
$388.8M
$9.72B
1M return
+11.11%
+72.25%
1Y return
+11.11%
+65.80%
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
0
11
Recent ratings
13
22
AKYA

Akoya BioSciences Inc.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

BRKR

Bruker Corporation

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Latest AKYA

Latest BRKR